"
Template:SupbiotechparisEn
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 70: | Line 70: | ||
<span style="color: black;">'''Implementation'''</span> | <span style="color: black;">'''Implementation'''</span> | ||
[[Team:SupBiotech-Paris/Tissue targeting#drapeau|Tissue targeting]] | [[Team:SupBiotech-Paris/Tissue targeting#drapeau|Tissue targeting]] | ||
| - | [[Team:SupBiotech-Paris/ | + | [[Team:SupBiotech-Paris/Antitumoral_action#drapeau|Antitumor action]] |
[[Team:SupBiotech-Paris/Treatement_modeling#drapeau|Treatment modeling]] | [[Team:SupBiotech-Paris/Treatement_modeling#drapeau|Treatment modeling]] | ||
[[Team:SupBiotech-Paris/Conclusion3#drapeau|Conclusion]] | [[Team:SupBiotech-Paris/Conclusion3#drapeau|Conclusion]] | ||
Revision as of 14:48, 18 October 2009
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
BioBricks Material & Method Bibliography
Ethic & Safety
